CHO-EGFR Cells
2 622,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | Disclaimer: The prices displayed for cell lines are exclusively for academic/not-for-profit customers. For commercial entitites the price is approximately €6,250. CHO-EGFR cells are recombinant Chinese hamster ovary (CHO) cells engineered to stably express human epidermal growth factor receptor (EGFR/ERBB1/HER1), a receptor tyrosine kinase belonging to the ErbB family. EGFR regulates key cellular processes including proliferation, survival, migration, and differentiation through activation of downstream signaling pathways such as MAPK/ERK, PI3K/AKT, and JAK/STAT. Aberrant EGFR expression, amplification, or mutation is frequently associated with multiple solid tumors, including non-small cell lung cancer, colorectal cancer, glioblastoma, and head and neck squamous cell carcinoma. Stable CHO-EGFR models provide a controlled platform for investigating receptor biology and therapeutic targeting. CHO-EGFR cells are widely used in oncology research and biologics development for characterization of anti-EGFR monoclonal antibodies, tyrosine kinase inhibitors, bispecific antibodies, antibody-drug conjugates, and engineered immune cell therapies. These cells support quantitative assessment of ligand binding, receptor activation, internalization, phosphorylation status, downstream signaling, and therapeutic blockade. They are also commonly employed in flow cytometry assays, receptor occupancy studies, high-throughput screening, and potency testing workflows. Because CHO cells provide robust growth characteristics and relatively low endogenous expression of human receptor systems, they offer a reproducible background for recombinant EGFR expression and standardized assay development. |
|---|---|
| Organisme | Chinese hamster |
| Tissu | Ovary |
| Maladie | Chinese hamster ovary, non-neoplastic; genetically engineered for EGFR surface expression |
| Applications | Antibody screening; EGFR-targeted therapy development; ADCC/CDC assays; lung/colorectal cancer research; flow cytometry |
Caractéristiques
| Âge | Adult |
|---|---|
| Genre | Female |
| Morphologie | Epithelial-like |
| Type de cellule | Epithelial cell of ovary |
| Propriétés de croissance | Adherent/suspension |
Données réglementaires
| Référence | CHO-EGFR (Cytion catalog number 305977) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 10029 |
| Cellosaurus - Numéro d'enregistrement | CVCL_A8W3 |
| Statut OGM | GMO-S1: This CHO cell line contains an EGFR expression cassette supporting receptor-function analyses. This classification applies only within Germany and may differ elsewhere. |
Données biomoléculaires
| Antigènes de surface | EGFR (HER1/ErbB1/CD340) |
|---|
Manipulation
| Milieu de culture | For adherent cultures: DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) For suspension cultures: CHO Growth Medium A (from InSCREENeX; InSCREENeX catalog number INS-ME-1039) |
|---|---|
| Suppléments | For adherent cultures: Supplement the medium with 5% FBS. Add Geneticin (G418-Sulfat) to achieve a final concentration of 0.5 mg/mL. |
| Réactif de dissociation | For adherent cultures: Trypsin-EDTA |
| Temps de doublement | approx. 14-16 hours |
| Repiquage | For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C for 5-10 minutes, or until the cells detach. Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days. |
| Rapport de fractionnement | 1 to 5 |
| Densité de semis | 2 to 5 x 104 cells/cm2 |
| Renouvellement des fluides | 2 to 3 times per week |
| Rétablissement après le dégel | After thawing, split the cells at a ratio of 1:2 to 1:3 in T25 flasks and allow the cells to recover from the freezing process and to adhere (for adherent cultures) for at least 24 hours. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|